SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000006
Filing Date
2018-01-25
Accepted
2018-01-25 08:29:21
Documents
3
Period of Report
2018-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebio-form8xkfitzgeraldappo.htm 8-K 33928
2 EXHIBIT 10.1 fitzgerald-elevenbioemploy.htm EX-10.1 61398
3 fitzgeraldelevenbioem_image1.jpg GRAPHIC 89522
  Complete submission text file 0001485003-18-000006.txt   219722
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18546681
SIC: 2834 Pharmaceutical Preparations